Skip to Main Content

Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment

Conditions

Diseases of the Respiratory Systems | COVID-19 Inpatient

Phase COVID-III

What is the purpose of this trial?

The primary objective of this study is to evaluate the efficacy of 2 remdesivir (RDV) regimens compared to standard of care (SOC), with respect to clinical status assessed by a 7-point ordinal scale on Day 11.

  • Trial with
    Gilead Sciences
  • Start Date
    03/20/2020
  • End Date
    05/30/2020
Trial Image

For more information about this study, contact:

Laurie Andrews

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    07/17/2020
  • Study HIC
    #2000027734